Laura Tietzmann Grevet

Laura Tietzmann Grevet

Auto-generated profile, based on publicly available information

Laura Tietzmann Grevet

School of Medicine, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2023 in BMJ Mental Health
Verified
Journal Article
Open access
PDF file
LMLuis Souza Motta
Luis Souza Motta
NGNatan Pereira Gosmann
Natan Pereira Gosmann
MCMarianna de Abreu Costa
Marianna de Abreu Costa
MJMarianna de Barros Jaeger
Marianna de Barros Jaeger
JFJúlia Frozi
Júlia Frozi
GSGiovanni Salum
Giovanni Salum
Question Randomised controlled trials assessing treatments for anxiety, obsessive-compulsive and stress-related disorders often present high placebo response rates in placebo groups. Understanding the placebo response is essential in accurately estimating the benefits of pharmacological agents; nevertheless, no studies have evaluated the placebo response across these disorders using a lifespan approach. Study selection and analysis We searched MEDLINE, PsycINFO, Embase, Cochrane, websites of regulatory agencies and international registers from inception to 9 September 2022. The primary outcome was the aggregate measure of internalising symptoms of participants in the placebo arms of randomised controlled trials designed to assess the efficacy of selective serotonin reuptake inhibitors (SSRIs) and serotonin and norepinephrine reuptake inhibitors (SNRIs) in individuals diagnosed with anxiety, obsessive-compulsive or stress-related disorders. The secondary outcomes were placebo response and remission rates. Data were analysed through a three-level meta-analysis. Findings We analysed 366 outcome measures from 135 studies (n=12 583). We found a large overall placebo response (standardised mean difference (SMD)=−1.11, 95% CI −1.22 to −1.00). The average response and remission rates in placebo groups were 37% and 24%, respectively. Larger placebo response was associated with a diagnosis of generalised anxiety disorder and post-traumatic stress disorder, when compared with panic, social anxiety and obsessive-compulsive disorder (SMD range, 0.40–0.49), and with absence of a placebo lead-in period (SMD=0.44, 95% CI 0.10 to 0.78). No significant differences were found in placebo response across age groups. We found substantial heterogeneity and moderate risk of bias. Conclusions Placebo response is substantial in SSRI and SNRI trials for anxiety, obsessive-compulsive and stress-related disorders. Clinicians and researchers should accurately interpret the benefits of pharmacological agents in contrast to placebo response. PROSPERO registration number CRD42017069090.

1 November 2025
Verified
Book Chapter
Closed access
LGLaura Tietzmann Grevet
Laura Tietzmann Grevet
MSMariana Martins Dantas Santos
Mariana Martins Dantas Santos
SPStella Duarte Pinto
Stella Duarte Pinto
YBYuri Ferreira Felloni Borges
Yuri Ferreira Felloni Borges
DCDanielle Irigoyen da Costa
Danielle Irigoyen da Costa
O desenvolvimento neuropsicomotor (DNPM) é um processo complexo de transformações definido por padrões de comportamento que acompanham as diversas etapas da vida de um indivíduo. O DNPM relaciona-se à idade cronológica e indica a integridade e maturidade do sistema nervoso. Envolve, portanto, a aquisição de novas habilidades em diferentes domínios do funcionamento humano (motor, cognitivo, socioemocional e adaptativo).

1 November 2025
Verified
Book Chapter
Closed access
PNPedro Rodrigues Neves
Pedro Rodrigues Neves
LGLaura Tietzmann Grevet
Laura Tietzmann Grevet
EWEduarda Kotlinsky Weber
Eduarda Kotlinsky Weber
YBYuri Ferreira Felloni Borges
Yuri Ferreira Felloni Borges
WMWilliam Alves Martins
William Alves Martins
Os neurologistas são frequentemente chamados ao departamento de emergência para avaliar vários distúrbios agudos primários do Sistema Nervoso Central e Periférico (SNC, SNP) ou complicações neurológicas de múltiplas doenças sistêmicas. As emergências neurológicas surgem frequentemente e, se não forem diagnosticadas e tratadas rapidamente, podem ter resultados devastadores, com altas taxas de incapacidade e morte a curto prazo, sendo que o reconhecimento imediato se torna uma habilidade importante nesse contexto.

1 November 2025
Verified
Book Chapter
Closed access
RSRodrigo Twardowski Scherer
Rodrigo Twardowski Scherer
LGLaura Tietzmann Grevet
Laura Tietzmann Grevet
LGLeidys Marina Pedrozo García
Leidys Marina Pedrozo García
WMWilliam Alves Martins
William Alves Martins
JBJefferson Becker
Jefferson Becker
A avaliação de pacientes em coma ou com alteração do estado mental é uma urgência médica. Ao identificar um paciente não responsivo, o exame físico neurológico é o primeiro método diagnóstico a ser utilizado, pois ajuda a determinar a conduta inicial e a urgência na solicitação de exames complementares. A alteração do estado mental envolve prejuízo da consciência, que pode ser subdividida em cognição, relacionada ao córtex cerebral, com comprometimento da percepção de si e do meio ambiente; e vigília, relacionada a porção rostral do tronco encefálico, com redução do nível de alerta e despertar.